MR‐1 can promote cell proliferation and migration of human liver cancer and breast cancer cells.[14, 15] Consistent with the above results, bioinformatics analysis showed that MR‐1 is overexpressed in NSCLC, which was also verified through in vitro experiments. Here, MR1 is linked to breast carcinoma.